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Jan 14, 2020 MRM data analysis. Peptides for metabolic enzymes were selected from iMPAQT database and subjected to chemical synthesis (Supplementary Table1). Obtained peptides were labeled with mTRAQ4 reagent and spiked into mTRAQ0-labled sample digests. The corresponding MRM transitions with the expected retention time were obtained from iMPAQT database. MRM was performed on a triplestage quadrupole MS instrument (QTRAP6500, SCIEX) coupled with nanoflow liquid chromatography (Eksigent nano-LC, SICEX). Endogenous peptide abundance was obtained by multiplication of the ratio of the light and heavy intensities summed for each transition and the known amount of synthetic peptide. Protein abundance was determined as the mean ± s.d. for the different peptides for each protein and replicate cultures (n = 3) for each cell line.
Principal component analysis was performed for the heat map derived from hierarchical clustering of measured metabolic enzymes with the use of JMP version 13. Meta-analysis was performed with the use of Review Manager 5.3. Immunoblot signals were quantified with the use of an ImageQuant LAS-4000 instrument and ImageQuant TL software TL 8.2 (GE Healthcare Life Sciences).
The MS data are available under the following site. Projects: Quantification of metabolic enzymes in TIG-3 TSM and AIG cells.
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All studies must disclose on these points even when the disclosure is negative. Validation ID: PXD009543 URL: https://repository.jpostdb.org preview/130108915ad96146e3c87 Access key: 6165. Meta-analysis: Lung; GSE5843, GSE11969, GSE26939, TGCA-LUAD, GSE11117, GSE14814, TGCA-LUSC, GSE13213, GSE17710, GSE30219, GSE3141, GSE37745, GSE19188, GSE41271, GSE50081, GSE42127. Breast; NKI, TGCA-BRCA, GSE7390, GSE3494_U133A, GSE1456_U133A, GSE37751, GSE42568, GSE1893-GPL887, GSE18229-GPL887, GSE19783-GPL6480, GSE21653, GSE2607-GPL1390, GSE2607-GPL887, GSE3143, GSE48390, GSE6130-GPL1390, GSE6130-GPL887, GSE9897. Brain; GSE7696, GSE13041_U133, GSE13041_U95v2, GSE16011, TGCA-GBM, TGCA-LGG, GSE16581, GSE2817, GSE30074, GSE37418, GSE42669, GSE4271_U133B, GSE4412_U133A. NEC, GSE62564, TGCA-PGPC. Liver; GSE10141, TGCA-LIHC. Pancreas; GSE21501, GSE28735, TGCA-PAAD, GSE50827, GSE57495, GSE71729. Colorectal; GSE28814, GSE17536, GSE17537, TGCA-COAD, GSE16125, GSE24551, GSE28772, GSE41258, GSE29621, GSE38832, GSE39852
We searched the public database PROGgene, which compiles cohort studies from public repositories such as GEO, EBI Array Express, and The Cancer Genome Atlas (TCGA). Studies compiled through 10 March 2018 were selected for inclusion in our meta-analysis on the basis of criteria including a study duration of >7 years, with most of the selected studies having a duration of 10 to 20 years. About 80 cohort studies met the inclusion criteria and were deemed appropriate for entry into the meta-analysis form the public database PROGgene. Twelve of these studies were subsequently excluded because some values were not clear or because of a single study being analyzed multiple times, leaving a final number of ~80 cohort studies entered into the meta-analysis ( Figure S6 ). Microarray or RNA-sequencing data for all metabolic enzymes in various organs are available online at PROGgene (http://watson.compbio.iupui.edu/chirayu/proggene/database/?url=proggene). Data were combined by means of fixed-effects or random-effects models for each organ. For integration of the HR for various organs, data were combined by means of the randomeffects model.
Antibodies to c-Myc (ab32072) and to GLS1 (ab60709; or ab93434 in Supplementary Figs. 7e and 10a) were obtained from Abcam, those to PPAT (15401-1AP) and PDHA1 (18068-1-AP) were from Proteintech, those to Hsp90 (610419) were from BD Transduction Laboratories, and those to GAPDH (ENZ ADI-CS) were from Enzo.
The specificity of each antibody was validated by the manufacturer, and provided on the website.
Twelve of these studies were subsequently excluded because some values were not clear or because of a single study being analyzed multiple times, leaving a final number of~80 cohort studies entered into the meta-analysis ( Figure S6 ).
Each experiment was repeated 3-6 times independently. For details, see manuscript.
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